Loading clinical trials...
Loading clinical trials...
Immunotherapy have revolutionized the field of oncology, but response rates are low and all patients relapse, due to immunologic (myeloid immunosuppressive cells) and non-immunologic (cancer stem- cel...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Bordeaux
NCT07668037 · Non-Small Cell Carcinoma of Lung, Immunotherapy, and more
NCT06159335 · Brain Metastasis, Radiation Therapy, and more
NCT06364917 · Non Small Cell Lung Cancer
NCT05076760 · Solid Tumor, Advanced Cancer, and more
NCT07267000 · Non-Small Cell Lung Cancer, Exercise Training, and more
CHU de Bordeaux, service d'Oncologie Médicale
Bordeaux
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions